Rezon Bio Appoints Dr. Ralf Otto as Chief Operating Officer to Strengthen Global CDMO Expansion Strategy Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), has announced…
HSS Surgeon Riley J. Williams III Appointed Venue Medical Officer for FIFA World Cup 26™ in New York–New Jersey Region FIFA World Cup 26™ has announced the appointment of Hospital…
Cellares and TScan Therapeutics Collaborate to Evaluate Automated Manufacturing for TSC-101 TCR-T Therapy in AML and MDS Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc.…
Mission Bio and German Research Consortium Identify Single-Cell Biomarker Signal That May Predict Motixafortide Benefit in AML Mission Bio, a leader in single-cell multiomics, has jointly announced new findings with…
Fujifilm Strengthens Life Sciences Leadership Across Biomanufacturing and iPSC Businesses FUJIFILM Holdings America Corporation has announced expanded leadership responsibilities for three senior executives across its Life Sciences Group, reinforcing the…
QT Imaging Secures Saudi FDA Approval for Breast Acoustic CT Scanner, Advancing Expansion Across Gulf Healthcare Market QT Imaging Holdings, Inc., a medical device company focused on transforming breast health…
Natera Appoints Oncology Leaders Thomas Lynch and Eric Rubin to Board of Directors to Strengthen Precision Medicine Strategy Natera, Inc., a global leader in cell-free DNA testing and precision medicine…
New Evidence Supports Ketogenic Therapy as a Potential Treatment for Anorexia Nervosa A pilot clinical study published in Communications Medicine has reported promising early evidence that a ketogenic nutritional intervention…
DocGo Expands PTI Health Mobile Phlebotomy Services Into Southern Florida Through Expanded Laboratory Partnership DocGo Inc., a leading provider of technology-enabled mobile health services and medical transportation solutions, has announced…
Terremoto Biosciences Receives FDA Fast Track Designation for TER-2013 in Advanced HR+/HER2- Breast Cancer Terremoto Biosciences, a biotechnology company focused on developing highly targeted small-molecule therapies for cancer, has announced…
Niagen Bioscience Renames Research Program to Strengthen Global Commitment to NAD+ Science and Healthy Aging Research Niagen Bioscience, Inc. (NASDAQ: NAGE), a company focused on advancing the science of healthy…
Gilead Reports Positive Phase 3 Results for Livdelzi in Primary Biliary Cholangitis, Demonstrating Significant Improvement in Liver Disease Marker Gilead Sciences has announced positive topline results from the Phase 3…